Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Methods of Documentation VI: Case Management Model

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CD137 in cancer therapy - bench to bedside.

Immunotherapy·2026

Same author

Socioeconomic Factors Impacting Survival in Patients with Hepatocellular Carcinoma Treated with Locoregional Therapies: A Single-Center Study.

Journal of vascular and interventional radiology : JVIR·2026

Same author

Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic Abilities of Erlotinib in Pancreatic Cancer.

Current cancer drug targets·2026

Same author

Yttrium-90 Radioembolization for Recurrent Meningioma: Rationale and Roadmap for Neurointerventional Translation.

Journal of neurointerventional surgery·2026

Same author

Cost-Effectiveness Analysis of Resection, Ablation and Radiation Segmentectomy for Solitary Hepatocellular Carcinoma ≤ 3 cm from a United States Payor's Perspective.

Journal of vascular and interventional radiology : JVIR·2026

Same author

Decreasing Administrative Effort Related to Non-Approval of Image-guidED Procedures Using Large Language Models - The DENIED-AI Pilot Study.

Academic radiology·2026

Search research articles

Related Experiment Videos

Multidisciplinary clinics in cancer-models, metrics, and meaning: a review.

Seohyuk Lee¹, Jim W Doolin², David E Avigan³

¹Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.

|June 4, 2026

Summary

This summary is machine-generated.

Cancer multidisciplinary clinics (MDCs) show varied structures and quality measures. While some studies report improved survival, more research is needed to understand the full impact of different MDC models on cancer care outcomes.

Keywords:

cancer models multidisciplinary clinic outcomes

Related Experiment Videos

Area of Science:

Oncology
Healthcare Management
Clinical Research

Background:

Multidisciplinary clinics (MDCs) are increasingly common in cancer care.
Existing models of cancer MDCs lack comprehensive comparative studies.
Understanding the structural elements and quality measures of MDCs is crucial for optimizing cancer patient care.

Purpose of the Study:

To characterize the structural elements of cancer multidisciplinary clinics (MDCs) in the United States.
To review reported quality measures across different MDC models.
To identify gaps in current understanding regarding MDC effectiveness and heterogeneity.

Main Methods:

A narrative review of 41 unique cancer MDCs across various cancer types (breast, GI, GU, HN, lung, other).
Analysis of structural components such as meeting frequency, patient evaluation type, and discussion synchronicity.
Examination of reported outcome measures, including overall survival and process measures.

Main Results:

MDCs most frequently convened weekly and evaluated new patients.
Asynchronous models were common in breast, GU, and lung cancers, while HN MDCs were synchronous.
While 70% of studies reported outcome measures, only 46% of those showed statistically significant improvements in overall survival with MDCs.
Process measures were examined in lung, GI, breast, and HN MDCs, but structure and balance measures were less frequently reported.

Conclusions:

Significant heterogeneity exists in the structure and reported outcomes of cancer MDCs.
Current understanding is limited by disparate reports and a lack of comparative studies.
Further research is essential to elucidate the impact of diverse MDC models on cancer care outcomes across different diagnoses.